ATE518138T1 - Stabilisierung von konjugaten mit einem thiourea- binder - Google Patents

Stabilisierung von konjugaten mit einem thiourea- binder

Info

Publication number
ATE518138T1
ATE518138T1 AT08020499T AT08020499T ATE518138T1 AT E518138 T1 ATE518138 T1 AT E518138T1 AT 08020499 T AT08020499 T AT 08020499T AT 08020499 T AT08020499 T AT 08020499T AT E518138 T1 ATE518138 T1 AT E518138T1
Authority
AT
Austria
Prior art keywords
thiourea
conjugate
conjugates
stabilization
binder
Prior art date
Application number
AT08020499T
Other languages
German (de)
English (en)
Inventor
Rene Blind
Gerhard Fink
Eva Hoess
Hans-Joachim Kytzia
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE518138T1 publication Critical patent/ATE518138T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08020499T 2007-11-30 2008-11-26 Stabilisierung von konjugaten mit einem thiourea- binder ATE518138T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07023206 2007-11-30

Publications (1)

Publication Number Publication Date
ATE518138T1 true ATE518138T1 (de) 2011-08-15

Family

ID=39271113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08020499T ATE518138T1 (de) 2007-11-30 2008-11-26 Stabilisierung von konjugaten mit einem thiourea- binder

Country Status (7)

Country Link
US (1) US20110112291A1 (cg-RX-API-DMAC7.html)
EP (1) EP2065705B1 (cg-RX-API-DMAC7.html)
JP (1) JP5523695B2 (cg-RX-API-DMAC7.html)
CN (1) CN101445503A (cg-RX-API-DMAC7.html)
AT (1) ATE518138T1 (cg-RX-API-DMAC7.html)
CA (1) CA2645309C (cg-RX-API-DMAC7.html)
ES (1) ES2369717T3 (cg-RX-API-DMAC7.html)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112930A (en) * 1975-04-08 1976-01-31 Kumiai Chemical Industry Co Anteiseiryokonaru noengeiyosakinsoseibutsu
JPS5718605A (en) * 1980-07-07 1982-01-30 Kumiai Chem Ind Co Ltd Stable insecticidal composition
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
JPS5855417A (ja) * 1981-09-27 1983-04-01 Nitto Electric Ind Co Ltd 医薬組成物
AU2541592A (en) * 1991-08-01 1993-03-02 Hybritech Incorporated Improvements in or relating to modified haptens useful as imaging and therapeutic agents
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
WO1995006877A1 (en) * 1993-09-03 1995-03-09 Behringwerke Ag Fluorescent oxygen channeling immunoassays
IT1298693B1 (it) * 1996-04-24 2000-01-12 Hoffmann La Roche Derivati della fluoresceina 4'-metil sostituiti
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF
US6586628B2 (en) * 2000-05-10 2003-07-01 The United States Of America, As Represented By The Secretary Of Agriculture 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
US7371524B2 (en) * 2003-06-17 2008-05-13 Hannjorg Hereth Substituted azaporphyrins as fluorescence labels
DE102004045748A1 (de) * 2004-09-21 2006-04-06 Roche Diagnostics Gmbh Stöchiometrisch definierte farbstoffmarkierte Substanzen zur Messung der glomerulären Filtrationsrate, ihre Herstellung und Verwendung
EP1795607A1 (en) * 2005-12-08 2007-06-13 Roche Diagnostics GmbH Stabilized cholinesterase substrate solution
NZ548931A (en) * 2006-05-15 2008-03-28 Wyeth Corp Stabilised formulation of moxidectin

Also Published As

Publication number Publication date
EP2065705A1 (en) 2009-06-03
ES2369717T3 (es) 2011-12-05
JP5523695B2 (ja) 2014-06-18
CA2645309C (en) 2016-07-19
CA2645309A1 (en) 2009-05-30
JP2009132716A (ja) 2009-06-18
EP2065705B1 (en) 2011-07-27
US20110112291A1 (en) 2011-05-12
CN101445503A (zh) 2009-06-03

Similar Documents

Publication Publication Date Title
CY1113485T1 (el) Ενωσεις γεφυρωμενης-πιπεριδινης τυπου υποκατεστημενης-κινοξαλινης και οι χρησεις εξ' αυτων
CR11454A (es) Derivados de isoxazolo-piridina
BRPI0607240A2 (pt) derivados de maleimida, composições farmacêuticas e métodos para tratamento de cáncer
CY1110925T1 (el) Νεες ενωσεις
EP1951729A4 (en) OXYGEN-BOUND PYRIMIDINE DERIVATIVES
WO2009046841A8 (de) Piperidin- und piperazinderivate zur behandlung von tumoren
CY1109696T1 (el) Υποκατεστημενα παραγωγα πυριδινυλιου και πυριμιδινυλιου ως διαμορφωτες του μεταβολισμου και η θεραπεια των σχετικων με αυτον διαταραχων
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
CO6290692A2 (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico
TR201900176T4 (tr) Anti-TROP2 antikor-ilaç konjugatı.
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
MX2013004242A (es) Sulfonamidas nematocidas.
DK2074120T3 (da) Tropan-forbindelser
EA200870615A1 (ru) Производные лептомицина
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
EP2408470A4 (en) SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE
WO2009071524A3 (en) Indolinone derivatives and process for their manufacture
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
WO2007021937A3 (en) Unsaturated heterocyclic derivatives
BR112014014464A2 (pt) uso de n-hidroxisuccinimida para melhorar a estabilidade do conjugado
DE602007008662D1 (de) Phosphitzusammensetzung und Herstellungsverfahren dafür
SG179405A1 (en) Additive for polishing composition
ECSP088826A (es) Compuestos heterocíclicos apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5ht6
UY29366A1 (es) Derivados de la n-(4,5-difenil-2-tienil)metilamina, su preparacion y su aplicación en terapéutica
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2065705

Country of ref document: EP